• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Intuitive Surgical shares jump on FDA clearance for new da Vinci robot

Intuitive Surgical shares jump on FDA clearance for new da Vinci robot

April 1, 2014 By Brad Perriello

Intuitive Surgical shares jump on FDA clearance for new da Vinci robot

Intuitive Surgical (NSDQ:ISRG) shares opened up 11% this morning, after the medical device company said the FDA cleared the latest version of its da Vinci surgical robot, and quickly surged past the $500 mark..

Intuitive said it plans to have its da Vinci Xi device immediately on the U.S. market now that it’s got 510(k) clearance from the FDA, and "will be seeking regulatory clearances to market the da Vinci Xi System around the world."

"Our goal is to develop technology that enhances surgical performance," president & CEO Gary Guthart said in prepared remarks. "The da Vinci Xi System’s new overhead architecture means that multi-quadrant surgery can be performed without repositioning the system, an innovation long sought by surgeons who perform complex procedures. We strive to provide the most advanced, least invasive option for surgery, and we are working hard to make minimally invasive surgery the standard of care."

Intuitive said the Xi system "can be used across a wide spectrum of minimally invasive surgical procedures and has been optimized for complex, multi-quadrant surgeries." Other enhancements include improved overhead architecture of the devices 5 arms "to facilitate anatomical access from virtually any position" and new joints for greater range of motion, according to a press release. Intuitive said it also improved the endoscope on the da Vinci Xi for "a simpler, more compact design with improved visual definition and clarity" and to enable it to be attached to any of the device’s arms. The new da Vinci also has longer instrument shafts "to give surgeons greater operative reach," the company said.

The da Vinci Xi is designed to accommodate Intuitive’s Firefly fluorescent imaging system, although the FDA hasn’t cleared Firefly for use with the Xi yet, according to the release. Intuitive said it plans to seek clearance for use of the Firefly with the da Vinci Xi and will continue to offer its older da Vinci Si and Si-e systems.

ISRG shares gained 9.8% in pre-market trading, to $481 apiece as of about 9:20 this morning, before opening at $486.05, up 11.0%. Shares were trading at $501.77 each by about 10 a.m., up 14.6%.

Last week Intuitive recalled cannulae used during procedures with da Vinci procedures, saying they can become damaged if not installed properly.

Filed Under: Food & Drug Administration (FDA), News Well, Surgical Robotics Tagged With: Intuitive Surgical

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy